Loading company…
Georgia regenerative medicine company selling placental tissue products such as EPIFIX for wound care and surgery.
Founded in 2008 in Georgia, US, and based in Marietta, MiMedx Group, Inc. works in regenerative medicine, focusing on advanced wound care and surgical solutions. Its products, including EPIFIX, EPICORD and AMNIOFIX, are placental tissue allografts sold mainly in the United States to clinicians and hospitals. The company received a USD 4.6 mn grant from the Medical Technology Enterprise Consortium on May 31, 2022. Joseph H. Capper is CEO as of August 2025, and its listed stage is Series D.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in